Personal information

Verified email addresses

Biography

A resourceful scientist with over 13 years of broad expertise in immunology, cell biology, cancer immunotherapy, and host-pathogen interactions. Proven ability to support preclinical sciences for immunology, cancer immunotherapy and host-pathogen interactions.

Activities

Employment (9)

Georgetown University School of Medicine: Washington DC, District of Columbia, US

2023-09-01 to 2024-08-31 | Postdoctoral Fellow (Department of Biochemistry, Molecular, and Cellular Biology)
Employment
Source: Self-asserted source
VEERUPAXAGOUDA PATIL

University of Maryland, College Park: College Park, MD 20742, Maryland, US

2023-02-01 to 2023-07-31 | Faculty Specialist (Bioengneering)
Employment
Source: Self-asserted source
VEERUPAXAGOUDA PATIL

The Ohio State University: Wooster, Ohio, US

2019-05-17 to 2023-01-31 | Research Associate 1 (Animal Science)
Employment
Source: Self-asserted source
VEERUPAXAGOUDA PATIL

University of Maryland Baltimore: Baltimore, MD, US

2019-02-04 to 2019-05-17 | Postdoctoral Fellow (Pharmacology)
Employment
Source: Self-asserted source
VEERUPAXAGOUDA PATIL

Georgetown University Lombardi Comprehensive Cancer Center: Washington, US

2016-03-01 to 2019-02-01 | Research Scientist
Employment
Source: Self-asserted source
VEERUPAXAGOUDA PATIL

Karnataka Veterinary Animal and Fisheries Sciences University: Bīdar, IN

2014-02-01 to 2015-08-01 | Assistant Professor (Adjunct Faculty) (Veterinary Microbiology)
Employment
Source: Self-asserted source
VEERUPAXAGOUDA PATIL

Cordeliers Research Centre: Paris, FR

2012-12-01 to 2013-12-01 | Postdoctoral Fellow (Immunology, Cancer and Inflammation)
Employment
Source: Self-asserted source
VEERUPAXAGOUDA PATIL

University of Medicine and Dentistry of New Jersey: Newark, New Jersey, US

2009-09-15 to 2012-04-15 | Postdoctoral Fellow (Medicine)
Employment
Source: Self-asserted source
VEERUPAXAGOUDA PATIL

University of Vermont: Burlington, US

2007-05-20 to 2009-09-13 | Postdoctoral Fellow (Microbiology and Molecular Genetics)
Employment
Source: Self-asserted source
VEERUPAXAGOUDA PATIL

Education and qualifications (3)

Indian Institute of Science: Bangalore, Karnataka, IN

1999-11 to 2007-06 | PhD (Biochemistry)
Education
Source: Self-asserted source
VEERUPAXAGOUDA PATIL

Karnataka Veterinary Animal and Fisheries Sciences University: Bīdar, IN

1997 to 1999 | MVSc (Veterinary Microbiology, Vety. College, Bidar)
Education
Source: Self-asserted source
VEERUPAXAGOUDA PATIL

Karnataka Veterinary Animal and Fisheries Sciences University: Bīdar, IN

1992 to 1997 | BVSc & AH (Veterinary College, Bidar)
Education
Source: Self-asserted source
VEERUPAXAGOUDA PATIL

Works (17)

Evaluation of Efficacy of Surface Coated versus Encapsulated Influenza Antigens in Mannose–Chitosan Nanoparticle-Based Intranasal Vaccine in Swine

Vaccines
2024-06-11 | Journal article
Contributors: Dina Bugybayeva; Ekachai Dumkliang; Veerupaxagouda Patil; Ganesh Yadagiri; Raksha Suresh; Mithilesh Singh; Jennifer Schrock; Sara Dolatyabi; Olaitan C. Shekoni; Hadi M. Yassine et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Characterization of the Efficacy of a Split Swine Influenza A Virus Nasal Vaccine Formulated with a Nanoparticle/STING Agonist Combination Adjuvant in Conventional Pigs

Vaccines
2023-11-10 | Journal article
Contributors: Veerupaxagouda Patil; Juan F. Hernandez-Franco; Ganesh Yadagiri; Dina Bugybayeva; Sara Dolatyabi; Ninoshkaly Feliciano-Ruiz; Jennifer Schrock; Raksha Suresh; Juliette Hanson; Hadi Yassine et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Intradermal Vaccination against Influenza with a STING-Targeted Nanoparticle Combination Adjuvant Induces Superior Cross-Protective Humoral Immunity in Swine Compared with Intranasal and Intramuscular Immunization

Vaccines
2023-11-07 | Journal article
Contributors: Juan F. Hernandez-Franco; Ganesh Yadagiri; Veerupaxagouda Patil; Dina Bugybayeva; Sara Dolatyabi; Ekachai Dumkliang; Mithilesh Singh; Raksha Suresh; Fatema Akter; Jennifer Schrock et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Artificial Intelligence in Public Health: Revolutionizing Epidemiological Surveillance for Pandemic Preparedness and Equitable Vaccine Access

Vaccines
2023-06-26 | Journal article
Contributors: Pranav Anjaria; Varun Asediya; Prakrutik Bhavsar; Abhishek Pathak; Dhruv Desai; Veerupaxagouda Patil
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Data from IDO Vaccine Ablates Immune-Suppressive Myeloid Populations and Enhances Antitumor Effects Independent of Tumor Cell IDO Status

2023-04-04 | Preprint
Contributors: Rahul Nandre; Vivek Verma; Pankaj Gaur; Veerupaxagouda Patil; Xingdong Yang; Zainab Ramlaoui; Nour Shobaki; Mads Hald Andersen; Ayako Wakatsuki Pedersen; Mai-Britt Zocca et al.
Source: check_circle
Crossref

Data from IDO Vaccine Ablates Immune-Suppressive Myeloid Populations and Enhances Antitumor Effects Independent of Tumor Cell IDO Status

2023-04-04 | Preprint
Contributors: Rahul Nandre; Vivek Verma; Pankaj Gaur; Veerupaxagouda Patil; Xingdong Yang; Zainab Ramlaoui; Nour Shobaki; Mads Hald Andersen; Ayako Wakatsuki Pedersen; Mai-Britt Zocca et al.
Source: check_circle
Crossref

Supplementary Figure from IDO Vaccine Ablates Immune-Suppressive Myeloid Populations and Enhances Antitumor Effects Independent of Tumor Cell IDO Status

2023-04-04 | Preprint
Contributors: Rahul Nandre; Vivek Verma; Pankaj Gaur; Veerupaxagouda Patil; Xingdong Yang; Zainab Ramlaoui; Nour Shobaki; Mads Hald Andersen; Ayako Wakatsuki Pedersen; Mai-Britt Zocca et al.
Source: check_circle
Crossref

Supplementary Figure from IDO Vaccine Ablates Immune-Suppressive Myeloid Populations and Enhances Antitumor Effects Independent of Tumor Cell IDO Status

2023-04-04 | Preprint
Contributors: Rahul Nandre; Vivek Verma; Pankaj Gaur; Veerupaxagouda Patil; Xingdong Yang; Zainab Ramlaoui; Nour Shobaki; Mads Hald Andersen; Ayako Wakatsuki Pedersen; Mai-Britt Zocca et al.
Source: check_circle
Crossref

IDO Vaccine Ablates Immune-Suppressive Myeloid Populations and Enhances Antitumor Effects Independent of Tumor Cell IDO Status

Cancer Immunology Research
2022-05-03 | Journal article
Contributors: Rahul Nandre; Vivek Verma; Pankaj Gaur; Veerupaxagouda Patil; Xingdong Yang; Zainab Ramlaoui; Nour Shobaki; Mads Hald Andersen; Ayako Wakatsuki Pedersen; Mai-Britt Zocca et al.
Source: check_circle
Crossref

Intravenous immunoglobulin suppresses the polarization of both classically and alternatively activated macrophages

Human Vaccines & Immunotherapeutics
2020-02-01 | Journal article
Contributors: Chaitrali Saha; Prathap Kothapalli; Veerupaxagouda Patil; Gundallahalli Bayyappa ManjunathaReddy; Srini V Kaveri; Jagadeesh Bayry
Source: check_circle
Crossref

Monomeric Immunoglobulin A from Plasma Inhibits Human Th17 Responses In Vitro Independent of FcαRI and DC-SIGN

2017 | Journal article
Contributors: Saha, Chaitrali; Das, Mrinmoy; Patil, Veerupaxagouda; Stephen-Victor, Emmanuel; Sharma, Meenu; Wymann, Sandra; Jordi, Monika; Vonarburg, Cédric; Kaveri, Srini V.; Bayry, Jagadeesh
Source: Self-asserted source
VEERUPAXAGOUDA PATIL via BASE - Bielefeld Academic Search Engine

Autoantibodies in Therapeutic Preparations of Human Intravenous Immunoglobulin (IVIg)

Autoantibodies
2014 | Other
Contributors: Veerupaxagouda Patil; Jagadeesh Bayry; Sébastien Lacroix-Desmazes; Michel D. Kazatchkine; Srini V. Kaveri
Source: Self-asserted source
VEERUPAXAGOUDA PATIL via Crossref Metadata Search

Co-existence of classical and alternative activation programs in macrophages responding to Toxoplasma gondii

2013 | Other
Contributors: Patil, Veerupaxagouda; Zhao, Yanlin; Shah, Suhagi; Fox, Barbara A.; Rommereim, Leah M.; Bzik, David J.; Yap, George S.
Source: Self-asserted source
VEERUPAXAGOUDA PATIL via BASE - Bielefeld Academic Search Engine

The mechanisms of action of IVIG in autoimmune and inflammatory diseases

ISBT Science Series
2013-05 | Journal article
Part of ISSN: 1751-2816
Contributors: V. Patil; S. V. Kaveri
Source: Self-asserted source
VEERUPAXAGOUDA PATIL via Crossref Metadata Search

Disruption of the Expression of a Non-Coding RNA Significantly Impairs Cellular Differentiation in Toxoplasma gondii

2012 | Other
Contributors: Veerupaxagouda Patil; Pamela Lescault; Dario Lirussi; Ann Thompson; Mariana Matrajt
Source: Self-asserted source
VEERUPAXAGOUDA PATIL via BASE - Bielefeld Academic Search Engine

Genomic data reveal Toxoplasma gondii differentiation mutants are also impaired with respect to switching into a novel extracellular tachyzoite state.

2010 | Journal article
Contributors: Pamela J Lescault; Ann B Thompson; Veerupaxagouda Patil; Dario Lirussi; Amanda Burton; Juan Margarit; Jeffrey Bond; Mariana Matrajt
Source: Self-asserted source
VEERUPAXAGOUDA PATIL via BASE - Bielefeld Academic Search Engine

Peptidase N encoded by Salmonella enterica serovar Typhimurium modulates systemic infection in mice

2007 | Journal article
Contributors: Patil, Veerupaxagouda; Kumar, Anujith; Kuruppath, Sanjana; Nandi, Dipankar
Source: Self-asserted source
VEERUPAXAGOUDA PATIL via BASE - Bielefeld Academic Search Engine

Peer review (5 reviews for 2 publications/grants)

Review activity for Comparative clinical pathology. (4)
Review activity for Indian journal of microbiology. (1)